Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
74.7M
-
Shares change
-
+2.5M
-
Total reported value, excl. options
-
$1.74B
-
Value change
-
+$70.9M
-
Put/Call ratio
-
0.53
-
Number of buys
-
89
-
Number of sells
-
-74
-
Price
-
$23.26
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q1 2021
217 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q1 2021.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.7M shares
of 119M outstanding shares and own 62.59% of the company stock.
Largest 10 shareholders include BlackRock Inc. (11.9M shares), VANGUARD GROUP INC (4.9M shares), STATE STREET CORP (4.14M shares), FMR LLC (3.84M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (3.24M shares), Marshall Wace North America L.P. (2.7M shares), Polar Capital Holdings Plc (2.67M shares), WASATCH ADVISORS INC (2.61M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.56M shares), and Farallon Capital Management, L.L.C. (2.5M shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.